GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Cancer Medicine, Wiley, Vol. 3, No. 5 ( 2014-10), p. 1336-1341
    Abstract: Although pathological diagnosis is essential for managing malignant lymphoma, intraabdominal lesions are generally difficult to approach due to the invasiveness of abdominal surgery. Here, we report the use of percutaneous image‐guided coaxial core‐needle biopsy ( CNB ) to obtain intraabdominal specimens for diagnosing intraabdominal lymphomas, which typically requires histopathological and immunohistochemical evaluation. We retrospectively reviewed consecutive cases involving computed tomography ( CT )‐ or ultrasonography ( US )‐guided CNB to obtain pathological specimens for intraabdominal lesions from 1999 to 2011. Liver, spleen, kidney, and inguinal node biopsies were excluded. We compared CNB s with laparotomic biopsies. A total of 66 CNB s were performed for 59 patients (32 males, 27 females; median age, 63.5), including second or third repeat procedures. Overall diagnostic rate was 88.5%. None of the patients required additional surgical biopsies. Notably, the median interval between recognition of an intraabdominal mass and biopsy was only 1 day. Forty‐five procedures were performed for hematological malignancies. Adequate specimens were obtained for histopathological diagnosis in 86% of cases. Flow cytometry detected lymphoma cells in 79.5% of cases. Twelve patients (nine males, three females; median age, 60) were eligible for surgical biopsy. While every postoperative course was satisfactory, median duration from lesion recognition to therapy initiation for lymphoma cases was significantly shorter for CNB than for surgical biopsy (14 vs. 35 days). While one‐fourth of the patients were not eligible for the procedures, CNB is safe and highly effective for diagnosis of intraabdominal lymphomas. This method significantly improves sampling and potentially helps attain immunohistological distinction, allowing for more timely therapy initiation.
    Type of Medium: Online Resource
    ISSN: 2045-7634 , 2045-7634
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2014
    detail.hit.zdb_id: 2659751-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Transplant Infectious Disease, Wiley, Vol. 23, No. 3 ( 2021-06)
    Abstract: Little is known about the kinetics and clinical significance of saliva human herpesvirus‐6 (HHV‐6) DNA after hematopoietic stem cell transplantation (HSCT). Methods In this observational study, we quantified HHV‐6 DNA in serially collected plasma and saliva from allogeneic HSCT recipients. Associations between the status of salivary HHV‐6 DNA and the development of HHV‐6 encephalitis, depression, and oral mucosal graft‐versus‐host disease (GVHD) were retrospectively analyzed. Results A total of 787 plasma and 434 saliva samples were collected from 56 patients. The cumulative incidence of HHV‐6 DNA in plasma and saliva at 60 days after transplantation was 51.8% and 83.9%, respectively. The peak level of salivary HHV‐6 DNA was significantly higher in patients who displayed plasma HHV‐6 DNA than in those who did not (median, 51,584 copies/mL vs 587 copies/mL; P   〈  .0001). Salivary HHV‐6 DNA levels increased after positive plasma HHV‐6 DNA was detected and remained high during observation period. Despite the frequent occurrence of positive salivary HHV‐6 DNA, no patient developed depression. Positivity of salivary HHV‐6 DNA was not significantly associated with the development of HHV‐6 encephalitis ( P  = 1.00, Fisher's exact test) or oral mucosal GVHD ( P  = .71, Grey's test). No significant relationship between salivary HHV‐6 DNA and these diseases was found even when comparing higher HHV‐6 DNA loads in saliva. Conclusion Salivary HHV‐6 DNA levels increased after HHV‐6 DNA was detected in the blood. However, no epidemiological evidence was shown to support a role of salivary HHV‐6 in the development of HHV‐6 encephalitis, depression, and oral mucosal GVHD.
    Type of Medium: Online Resource
    ISSN: 1398-2273 , 1399-3062
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2010983-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...